
Serum Institute of India, the world’s largest vaccine manufacturer, will soon start clinical trials in the country to test if tuberculosis vaccine VPM1002 is effective as a preventive and immunity booster vaccine against Covid-19.
from Industry-Economic Times https://ift.tt/2wzHZD2
via
Latest News of India
Post a Comment